Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT
TRUST CT
1 other identifier
observational
117
4 countries
5
Brief Summary
Multicentric, observational, registry-based study of 0.9 mg/kg i.v. thrombolysis in wake-up stroke or stroke with unknown onset based on non-contrast CT appearance only
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2017
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 14, 2018
CompletedFirst Posted
Study publicly available on registry
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 4, 2019
February 1, 2019
1.3 years
August 14, 2018
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
sICH
symptomatic ICH according to ECASS3
72hours
Secondary Outcomes (1)
mRS 90 days
90 days
Eligibility Criteria
wake-up stroke, unknown onset stroke
You may qualify if:
- Ischemic stroke with NIHSS ≥ 4
- Wake-up stroke or unknown onset stroke
- Age ≥ 18 years
- rtPA Bolus within 4.5h of awakening and/or within 4.5 of discovering symptoms
- rtPA Bolus within 30 min. of admission CT
You may not qualify if:
- Noncontrast cranial CT scan with ASPECTS \< 7
- Evidence of intracranial or subarachnoid hemorrhage
- Inability to control systolic BP \>185mm Hg, or diastolic BP \>110mm Hg with IV antihypertensive medication
- Known coagulopathy or evidence of active bleeding
- Surgical procedures, subclavian arterial puncture, trauma, and gastrointestinal or genitourinary bleeding within 14 days of the event
- Patients taking oral anticoagulants and having an INR \>1.7
- A platelet count \<100 000, venous glucose either \<50 or \>450
- Premorbid mRS \> 3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- St John of God Hospital, Viennacollaborator
Study Sites (5)
St. Johns Hospital Vienna
Vienna, Austria
University Hospital Tuebingen
Tübingen, 72076, Germany
University Hospital Bratislava
Bratislava, Slovakia
General Hospital Liptovsky Mikulas
Liptovský Mikuláš, Slovakia
Lausanne University Hospital
Lausanne, Switzerland
Related Publications (1)
Sykora M, Kellert L, Michel P, Eskandari A, Feil K, Remi J, Ferrari J, Krebs S, Lang W, Serles W, Siarnik P, Turcani P, Kovacik M, Bender B, Mengel A, Poli K, Poli S. Thrombolysis in Stroke With Unknown Onset Based on Non-Contrast Computerized Tomography (TRUST CT). J Am Heart Assoc. 2020 Feb 18;9(4):e014265. doi: 10.1161/JAHA.119.014265. Epub 2020 Feb 12.
PMID: 32067594DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director
Study Record Dates
First Submitted
August 14, 2018
First Posted
August 16, 2018
Study Start
September 1, 2017
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
February 4, 2019
Record last verified: 2019-02